Deciduous Therapeutics Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Deciduous Therapeutics is a biotechnology research company based in San Francisco, California. It is exploring ways to treat age-related diseases by eliminating senescent cells, which accumulate when immune surveillance falters and drive local inflammation and tissue remodeling. The company has identified molecules that activate an endogenous immune mechanism to selectively remove these cells, aiming to address multiple age-associated conditions. The team is described as small to mid-sized, reflecting an early-stage biotechnology startup footprint.

Senescent cells lose function and release inflammatory signals that can alter their surrounding tissue and contribute to metabolic and fibrotic outcomes. By leveraging an intrinsic immune process to clear senescent cells, the company seeks therapies that could improve health-span across various diseases linked to aging. In October 2021, Deciduous Therapeutics announced the appointment of Robert Forrester to its independent board, marking a notable governance development.

Sign up for free to view info

Company overview Employee directory